Site Home   Gender and Cardiovascular Disease       Introduction to Gender and Health   The Gender Lens Tool

Studies indicate that men and women differ significantly in their lipid ratio profiles. For example, females have higher high density lipoprotein levels and lower triglyceride levels than men[1][2]. Moreover, the controlled animal studies have demonstrated that lipid level differences are, in part, sex-related. Researchers associate these differences with less fatty steak formation in the females, concluding that the metabolism of the same lipid diet and consequently the production of fatty streak are sex-dependent[3]. Although, this sex-related difference may be the result of multiple factors such as hormones, vessel wall, monocyte, or macrophage interaction differences. Buchanan[4] suggests that there is ultimately a difference in male and female metabolism of lipid, therefore, the treatment of hyperlipidemia should also be sex related.

 

There may also be a difference in the treatment of dyslipidemia in men and women with known coronary artery disease.  Both men and women, but especially women, were found to be undertreated with lipid-lowering agents in a study at North American academic medical centres.[5]

 

_________________________________

1. Redberg, R.F., (1998) Diagnostic Testing for Coronary Artery Disease in Women and Gender Differences in Referral for Revascularization. Cardiology Clinics, 16(1): 67-77.

2. Mosca, L., Grundy, S.M., Judelson, D., (1999) Guide to Preventive Cardiology for Women. Circ, 99:2480-2484.

3. Wilson, T.A., Nicolosi, R.J., Lawton, C.W., Babiak, J. (1999) Gender Differences in Response to a Hypercholestrolemic Diet in Hamsters: Effects on Plasma Lipoprotein Cholestrol Concentrations and Early Aortic Atherosclerosis. Atherosclerosis, 146:83-91.

4. Buchanan, M., Brister, S., (2000) Sex Related Differences in The Pathophysiology of Cardiovascular Disease: Is There A Rational For Sex-Related Treatments? Canadian Cardiovascular Society Consensus Conference: Women and Ischemic Heart Disease, October 2000: 2/1-2/28.

5. Miller M, et al. (PREVENT) investigators. Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and Canada. Arch Intern Med 2000;160:343-347 accessed March 28, 2006 http://archinte.ama-assn.org/cgi/content/abstract/160/3/343

All references for this section